Your browser doesn't support javascript.
loading
Labile plasma iron levels predict survival in patients with lower-risk myelodysplastic syndromes.
de Swart, Louise; Reiniers, Chloé; Bagguley, Timothy; van Marrewijk, Corine; Bowen, David; Hellström-Lindberg, Eva; Tatic, Aurelia; Symeonidis, Argiris; Huls, Gerwin; Cermak, Jaroslav; van de Loosdrecht, Arjan A; Garelius, Hege; Culligan, Dominic; Macheta, Mac; Spanoudakis, Michail; Panagiotidis, Panagiotis; Krejci, Marta; Blijlevens, Nicole; Langemeijer, Saskia; Droste, Jackie; Swinkels, Dorine W; Smith, Alex; de Witte, Theo.
Afiliación
  • de Swart L; Department of Hematology, Radboud university medical center, Nijmegen, the Netherlands.
  • Reiniers C; Department of Hematology, University Medical Centre, Groningen, the Netherlands.
  • Bagguley T; Epidemiology and Cancer Statistics Group, University of York, UK.
  • van Marrewijk C; Department of Hematology, Radboud university medical center, Nijmegen, the Netherlands.
  • Bowen D; St. James's Institute of Oncology, Leeds Teaching Hospitals, UK.
  • Hellström-Lindberg E; Department of Medicine, Division of Hematology, Karolinska Institutet, Stockholm, Sweden.
  • Tatic A; Center of Hematology and Bone Marrow Transplantation, Fundeni Clinical Institute, Bucharest, Romania.
  • Symeonidis A; Department of Medicine, Division of Hematology, University of Patras Medical School, Greece.
  • Huls G; Department of Hematology, University Medical Centre, Groningen, the Netherlands.
  • Cermak J; Department of Clinical Hematology, Institute of Hematology & Blood Transfusion, Prague, Czech Republic.
  • van de Loosdrecht AA; Department of Hematology - Cancer Center Amsterdam VU University Medical Center, The Netherlands.
  • Garelius H; Department of Medicine, Section of Hematology and Coagulation, Sahlgrenska University Hospital, Göteborg, Sweden.
  • Culligan D; Department of Haematology, Aberdeen Royal Infirmary, UK.
  • Macheta M; Department of Haematology, Blackpool Victoria Hospital, Lancashire, UK.
  • Spanoudakis M; Department of Haematology, Airedale NHS trust, UK.
  • Panagiotidis P; Department of Hematology, Laikon General Hospital, National and Kapodistrian University of Athens, Greece.
  • Krejci M; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Masaryk University, Czech Republic.
  • Blijlevens N; Department of Hematology, Radboud university medical center, Nijmegen, the Netherlands.
  • Langemeijer S; Department of Hematology, Radboud university medical center, Nijmegen, the Netherlands.
  • Droste J; Department of Hematology, Radboud university medical center, Nijmegen, the Netherlands.
  • Swinkels DW; Department of Laboratory Medicine, Hepcidinanalysis.com, and Radboudumc expertise center for iron disorders, Radboud university medical center, Nijmegen, the Netherlands and.
  • Smith A; Department of Hematology, University Medical Centre, Groningen, the Netherlands.
  • de Witte T; Nijmegen Center for Molecular Life Sciences, Department of Tumor Immunology, Radboud university medical center, the Netherlands theo.dewitte@radboudumc.nl.
Haematologica ; 103(1): 69-79, 2018 01.
Article en En | MEDLINE | ID: mdl-29122992

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Síndromes Mielodisplásicos / Hierro Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Haematologica Año: 2018 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Síndromes Mielodisplásicos / Hierro Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Haematologica Año: 2018 Tipo del documento: Article País de afiliación: Países Bajos